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Summary
 
Listeria monocytogenes
 
 is widely used as a model to study immune responses against intracellular
bacteria. It has been shown that neutrophils and macrophages play an important role to restrict
bacterial replication in the early phase of primary infection in mice, and that the cytokines in-
terferon-
 
g
 
 (IFN-
 
g
 
) and tumor necrosis factor-
 
a
 
 (TNF-
 
a
 
) are essential for protection. How-
ever, the involved signaling pathways and effector mechanisms are still poorly understood. This
study investigated mouse strains deficient for the IFN-dependent transcription factors inter-
feron consensus sequence binding protein (ICSBP), interferon regulatory factor (IRF)1 or 2 for
their capacity to eliminate 
 
Listeria
 
 in vivo and in vitro and for production of inducible reactive
nitrogen intermediates (RNI) or reactive oxygen intermediates (ROI) in macrophages.
ICSBP
 
2
 
/
 
2
 
 and to a lesser degree also IRF2
 
2
 
/
 
2
 
 mice were highly susceptible to 
 
Listeria
 
 infec-
tion. This correlated with impaired elimination of 
 
Listeria
 
 from infected peritoneal macrophage
(PEM) cultures stimulated with IFN-
 
g
 
 in vitro; in addition these cultures showed reduced and
delayed oxidative burst upon IFN-
 
g
 
 stimulation, whereas nitric oxide production was normal.
In contrast, mice deficient for IRF1 were not able to produce nitric oxide, but they efficiently
controlled 
 
Listeria
 
 in vivo and in vitro. These results indicate that (
 
a
 
) the ICSBP/IRF2 complex
is essential for IFN-
 
g
 
–mediated protection against 
 
Listeria
 
 and that (
 
b
 
) ROI together with addi-
tional still unknown effector mechanisms may be responsible for the anti-
 
Listeria
 
 activity of
macrophages, whereas IRF1-induced RNI are not limiting.
 
L
 
isteria monocytogenes
 
, a grampositive facultative intracel-
lular bacterium, infects macrophages and hepatocytes
in mice and has been used as a classic model to study im-
mune responses against intracellular bacteria (1). Neutrophile
granulocytes (2), 
 
gd
 
 T cells (3), and above all macrophages
(4) are important during the early phase of the immune re-
sponse. In SCID mice lacking mature B and T lympho-
cytes, NK cells activated by macrophage-derived TNF-
 
a
 
have been shown to activate the listericidal effector mecha-
nisms of macrophages via secretion of IFN-
 
g
 
 (5). These cells
are able to restrict initial replication of 
 
Listeria
 
 in murine
liver and spleen, since IFN-
 
g
 
 inhibits evasion of 
 
Listeria
 
from phagosomes into the cytoplasm (6). Specific T cells
are needed for final elimination of the pathogen (7) and also
for protection against secondary infection (8–10). Studies of
 
Listeria
 
 infection in mice deficient for IFN-
 
g
 
 (11), IFN-
 
g
 
receptor (12) or TNF receptor 1 (13) have shown that the
two cytokines IFN-
 
g
 
 and TNF-
 
a
 
 are crucial for survival.
However, the involved signaling pathways are not known,
and the effector mechanisms used by macrophages for kill-
ing of 
 
Listeria
 
 are still debated. The role of reactive oxygen
intermediates (ROI)
 
1
 
 (14–19) as well as reactive nitrogen
 
1
 
Abbreviations used in this paper:
 
 ICSBP, interferon consensus sequence
binding protein; i.f., into the footpad; iNOS, inducible nitric oxide syn-
thase; IRF1/2, interferon regulatory factor 1/2; ISGF, interferon-stimu-
lated gene factor; ISRE, interferon-stimulated response element; NO, ni-
tric oxide; PEM, peritoneal macrophage; RNI, reactive nitrogen
intermediates; ROI, reactive oxygen intermediates; STAT, signal trans-
ducers and activators of transcription.
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intermediates (RNI) (20–23) has been analyzed repeatedly;
these experiments revealed variations between different ex-
perimental setups and analyzed species.
Much information has accumulated about molecular and
in vivo biological function of IFNs over the past 15 years
(for review: see 24, 25). Two different pathways can be
distinguished: IFN-
 
a
 
 and -
 
b
 
 are binding to the type I IFN
receptor, whereas IFN-
 
g
 
 binds to the type II IFN receptor.
Analysis of gene-targeted mice deficient for only one (12, 26)
or both of these receptors (27) have revealed that depend-
ing upon the type of the pathogen these two systems are ei-
ther redundant or complementary in their antimicrobial ac-
tivity (for review see 28).
A variety of IFN-induced transcription factors have now
been described, most of them belonging to the structurally
related family of the interferon regulatory factors (IRFs) and
some being identical with signal transducers and activators of
transcription (STATs; Table 1). It has been revealed that
there is an overlap between the two IFN systems at the level
of transcription. Whereas some components of the inter-
feron-stimulated gene factor (ISGF) 3
 
a
 
 are only induced by
type I IFN (29), IRF1 (30, 31) and STAT1 (32, 33) can be
upregulated via both IFN receptors or by viruses directly
(31), and interferon consensus sequence binding protein
(ICSBP) is the prototype of a type II IFN-induced factor
(34, 35). IRF2 is omitted from Table 1, because the way of
its induction has not been clearly elucidated so far. The fact
that IRF2 is lacking in ICSBP 
 
2
 
/
 
2
 
 mice (36) suggests in-
duction via IFN-
 
g
 
 pathway. In vitro transfection systems
with reporter genes have revealed that IRF1 (37) and
ISGF3 (29) are activating transcription of genes containing
the interferon-stimulated response element (ISRE) in their
promotor sequence, whereas ICSBP (38) and IRF2 (37)
have repressor activity for ISRE-containing genes.
The generation of gene-targeted mice for the transcrip-
tion factors IRF1 (39, 40), IRF2 (39) and ICSBP (36) al-
lows to test for their biological role and their induction in
different infectious disease models, especially for activation
of macrophages. This study therefore evaluated the suscep-
tibility of these mouse strains to 
 
Listeria
 
 infection in vivo
and compared it to some macrophage effector functions
upon IFN-
 
g
 
 stimulation in vitro.
 
Materials and Methods
 
Mice.
 
Mice deficient for ICSBP (background C57BL6
 
3
 
129Sv), IRF1(129Sv), IRF2 (C57BL/6), IFN I and II receptor
(both 129Sv) were generated by gene targeting in embryonic
stem cells as described (12, 26, 36, 39). IRF1-deficient mice were
kindly provided by Prof. Charles Weissmann (Institute for Mo-
lecular Biology I, University of Zürich, Switzerland). IFN type I
receptor
 
2
 
/
 
2
 
 (A129) and IFN type II receptor
 
2
 
/
 
2
 
 (G129) mice
were obtained from the breeding colony of Prof. M. Aguet (Insti-
tute for Molecular Biology I, University of Zürich, Switzerland).
Control C57BL/6 or 129Sv mice as well as RAG2
 
2
 
/
 
2
 
 mice were
obtained from the Institute for Laboratory Animals (Veterinary
Hospital, Zürich, Switzerland). Mice were used at 6–10 wk of
age. The different breedings (except A129 and G129) and all the
experiments were performed under conventional (non-SPF) con-
ditions.
 
Listeria Culture and Infection. Listeria  monocytogenes
 
 was origi-
nally obtained from B. Blanden (Canberra, Australia). It was cul-
tured in trypticase soy broth (BBL Microbiology Systems, Cock-
eysville, MD), and overnight cultures were titrated on tryptose
blood agar plates (Difco Laboratories, Detroit, MI). For injection,
the original culture was diluted in BSS to inject the indicated
dose in 200 
 
m
 
l for i.v. or 30 
 
m
 
l for injection into the footpad (i.f.).
 
Determination of Bacterial Titers.
 
On the indicated days after
infection the whole spleen and one lobe of the liver were taken
out and homogenized. Bacterial titers were determined by plating
out four serial 10-fold dilutions of organ suspensions on tryptose
blood agar plates.
 
Adoptive Transfer of Spleen Cells.
 
On day 0, spleen single cell
suspensions were let to adhere to plastic to deplete them from
macrophages. After 2 h 3 
 
3
 
 10
 
7
 
 splenocytes were transferred into
nonirradiated RAG2
 
2
 
/
 
2
 
 recipients. On day 1 the recipients were
infected with 2 
 
3
 
 10
 
5
 
 CFU of 
 
Listeria
 
, and on day 10 liver and
spleen were taken out to determine bacterial titers.
 
Table 1.
 
Interferon Signal Transduction
 
Interferons
IFN type I (
 
a
 
/
 
b
 
) IFN type II (
 
g
 
)
Receptors
Type I IFN-R Type II IFN-R
Protein kinases
Only Type I Type I/II Only Type II
Tyk-2 Jak-1, PKC Jak-2
Transcription factors
Only Type I Type I/II Only Type II
ISGF-3a (
 
1
 
) STAT 1 (
 
1
 
) ISGF-3
 
g
 
 (
 
1
 
)
(
 
5 
 
STAT1b/STAT2
 
)(
 
5 
 
p 91 monomer
 
)(
 
5 
 
p48
 
)
IRF-1 (
 
1
 
) GAF (
 
1
 
)
(
 
5 
 
p91 dimer
 
)
ICSBP (
 
2
 
)
IFN-stimulated genes
Only type I Type I/II Only Type II
Mx-1 MHC class I MHC class II
IFN type I
iNOS
antimicrobicidal
activity
(
 
1
 
) Activator of ISRE-containing genes; (
 
2
 
) Repressor of ISRE-con-
taining genes. 
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Peritoneal Macrophage Cultures.
 
Peritoneal macrophages (PEM)
of different strains were elicited by injection of 2 ml of a starch so-
lution (2%; Merck, Darmstadt, Germany) intraperitoneally on day
 
2
 
5 and harvested on day 0 by rinsing the peritoneal cavity with
10 ml of cold BSS. The macrophages were washed three times
with BSS supplemented with albumin to prevent clumping and
then plated on cover slips in 24-well plates. Cells were cultured in
IMDM (Gibco, Basel, Switzerland) supplemented with 10% FCS,
glutamine, and 50 
 
m
 
g/ml gentamicin, an only extracellularly ef-
fective antibiotic. After 2 h of adherence the cover slips were
washed twice and put in 1 ml IMDM. The cultures were stimu-
lated with 200 ng/ml LPS, with 200 U/ml recombinant murine
IFN-
 
g
 
 (Genzyme, Cambridge, MA) or a combination of both for
42 h and then used for determination of nitric oxide (NO) pro-
duction, of respiratory burst or of 
 
Listeria
 
 killing in vitro. In those
cultures used for killing assays, the medium was changed to anti-
biotic-free after 24 h.
 
Determination of NO and Respiratory Burst.
 
NO production was
measured by determination of nitrite accumulation in PEM cul-
tures with Griess reagent (0.05% 
 
N
 
-1-naphthyl-ethylene-dia-
mine-dihydrochloride/0.5% sulfanilamide/2.5% phosphoric acid;
all from Fluka, Buchs, Switzerland) as described (41). In brief, 50 
 
m
 
l
cell culture supernatant was added to 150 
 
m
 
l Griess reagent in 96-
well plates and incubated at room temperature for 10 min. Ab-
sorption was read with an ELISA reader at 570 and 630 nm.
Respiratory burst was measured as H
 
2
 
O
 
2
 
 production by cul-
tured PEM upon PMA (Sigma, Buchs, Switzerland) stimulation
as described (18). In brief, H
 
2
 
O2 secretion of macrophages was
quantified by chemiluminescence under presence of horseradish
peroxidase type I (Sigma) and 5-amino-2,3-dihydro-1,4-phthala-
zinedione (luminol; Sigma) after triggering with 50 ng/ml PMA.
Light emission was discontinuously measured over 15 min in a LKB
1251 luminometer (LKB, Bromma, Sweden). Values in mV were
converted into pmol H2O2 after calibration by the scopoletin
method (42). The cells on the cover slips were counted, and val-
ues for NO and H2O2 calculated as nmol/105 cells. In Fig. 4 B
stimulation index of stimulated versus unstimulated cultures is
shown, because absolute values of respiratory burst varied be-
tween the experiments. PMA was used to trigger respiratory burst
because, as a chemically defined substance, it is the most reliable
burst trigger. Also opsonized Listeria, BCG or zymosan could be used
with similar capacities to trigger burst (23, 43), but more variability.
Because we investigated mouse strains deficient for various IFN-
dependent transcription factors, the induction phase of NADPH
oxidase during 2 d under IFN-g stimulation is important in our
experiment, whereas the effector phase of the burst trigger is only
used as read-out to measure the enzyme activity by providing the
best stimulator (PMA) and eccess of substrate (luminol).
In Vitro Killing Assay. PEM cultures in antibiotic-free me-
dium as described above were infected with 107 CFU of Listeria
from an overnight culture, washed three times and opsonized with
normal human serum. After 15 min of phagocytosis the infected
cultures were washed thoroughly, and gentamicin-containing me-
dium and the respective stimulators were added. To determine the
infection rate at time point t0, three cover slips were taken out.
The remaining ones were further cultured for 7 h to allow diges-
tion of Listeria by macrophages. After 7 h the cover slips were taken
out, dried, and then stained according to May-Grünwald-Giemsa.
For each mouse strain and each stimulation a total of 600 mac-
rophages were counted under the microscope to determine the
number of Listeria-infected cells. The change of infected macro-
phages was calculated in percentage of the infection rate at t0. For
details, see reference 18.
Immunohistochemistry. Mice infected with 5 3 103 CFU of
Listeria i.v. were sacrificed on day 5 or 6. Organs were immersed
in Hank’s BSS and frozen in liquid nitrogen. 5-mm cryosections
were fixed with acetone for 10 min, immunostained for Listeria
with a polyclonal rabbit anti-Listeria serum (diluted 1/2,000;
kindly provided by Professor J. Bille, Institute of Microbiology,
University Hospital of Lausanne, Switzerland) and for iNOS with
a polyclonal rabbit anti-iNOS serum (diluted 1/1,500; Biomol,
Plymouth, PA). Bound primary antibodies were detected using a
sandwich staining procedure. Sections were incubated with alka-
line phosphatase-labeled goat anti–rabbit Ig (diluted 1/80; Jackson
Laboratories, Bar Harbor, Maine) followed by alkaline phosphatase-
labeled donkey anti–goat Ig (diluted 1/80; Tago). Dilutions of sec-
ondary reagents were made in TBS containing 5% normal mouse
serum. All incubation steps were done for 30 min at room tem-
perature. Alkaline phosphatase was visualized using naphthol AS-
BI phosphate and New Fuchsin (Sigma) as substrate, which yields
a red color reaction product. Endogenous alkaline phosphatase
was blocked by levamisole. Sections were counterstained with
hemalum, and cover slips were mounted with glycerol/gelatin.
Results
Enhanced Bacterial Replication and Increased Lethality after
Listeria Monocytogenes Infection in ICSBP-deficient Mice.
Gene targeted mice deficient for ICSBP, IRF1, or IRF2
were infected with various doses of Listeria intravenously or
peripherally i.f., and survival was monitored daily (Table 2).
All ICSBP2/2 mice died after injection of a dose as low as
50 CFU of Listeria, whereas five of six IRF22/2 mice suc-
cumbed to a dose of 5 3 103 CFU within 12 d. In contrast,
IRF12/2 and wild-type mice resisted to a dose of 5 3 103
Table 2. Resistance of Different Mouse Strains against
Listeria Infection
Mouse strain Listeria dose
Route of
infection
Surviving/
infected
d6 d12
CFU
ICSBP2/2 5 3 103 i.v. 0/7 0/7
5 3 102 i.f. 0/7 0/7
5 3 101 i.f. 3/5 0/5
IRF12/2 5 3 103 i.v. 11/12* 5/6
IRF22/2 5 3 103 i.v. 12/13* 1/6
A129 5 3 103 i.v. 7/7 7/7
G129 5 3 103 i.v. 0/9 0/9
5 3 102 i.f. 5/6 0/6
5 3 101 i.f. 6/6 1/6
wt C57BL/6 5 3 103 i.v. 8/8 7/8
wt 129/Sv 5 3 103 i.v. 9/9 9/9
*Half of the mice were taken on day 5 to determine titers in livers and
spleens, the others monitored until day 12.924 Role of Interferon Consensus Sequence Binding Protein in Murine Listeriosis
CFU injected intravenously. However, IRF12/2 mice on
C57BL/6 background and held under strict SPF conditions
also showed enhanced susceptibility to Listeria, when in-
jected with a 5–10-times higher dose intraperitoneally
(Ferrick, D., and H.W. Mittrücker, personal communica-
tion). Listeria titers in liver and spleen were determined 24 h
after a high dose (2 3 105 CFU) and 5 d after an interme-
diate dose (5 3 103 CFU) of Listeria injected intravenously.
In the first 24 h, when neutrophils seem to play an impor-
tant role (2), there was almost no titer difference between
the three strains and only a 10-fold difference compared to
control mice (data not shown). However, after 5 d when
activated macrophages are essential for control of Listeria
infection, ICSBP2/2 and IRF22/2 showed between 102-
and 106-fold higher titers in liver and spleen, whereas
IRF12/2 mice controlled Listeria replication comparable to
controls (Fig. 1 A). In vitro gene regulation studies have re-
vealed that ICSBP and IRF2 form complexes which then
have a markedly enhanced DNA binding capacity to ISRE
compared to the single factors (44). In contrast to IRF1, they
are both negative regulators of classical IFN-induced genes.
However, both transcription factors are obviously of major
importance for early anti-Listeria immune responses. Since
it has been shown that ICSBP2/2 mice do not express
IRF2 (although the gene is intact [36]), this can explain the
even more drastic phenotype of ICSBP2/2 compared to
IRF22/2 mice, because they represent functionally a dou-
ble knock-out phenotype.
Competition of different transcription factors of the IRF
family at the DNA binding level has been demonstrated in
in vitro studies (45). It was therefore possible that lack of
IFN type I–induced transcription factors would lead to in-
creased activity of IFN type II–induced factors. To test this
in vivo, we infected mice deficient for the type II (G129)
or the type I (A129) IFN receptor and control mice (wt129)
with 5 3 103 CFU of Listeria and determined bacterial ti-
ters in liver and spleen on day 5 (Fig. 1 B). As demonstrated
earlier (12), G129 mice showed drastically enhanced bacte-
rial replication and lethality (Table 2), whereas A129 elimi-
nated the pathogen even more efficiently than wt129 mice.
This result suggests that competition between the two sig-
naling pathways at the transcription factor level occurs. IFN
type II–induced transcription factors (and among them es-
pecially ICSBP) may compensate for the lack of IFN type
I–induced factors in the A129 mouse, thereby conferring
even higher resistance to Listeria infection than in control
mice. Because early Listeria clearance in nude mice (46) has
been shown to be more efficient than in immunocompetent
controls because their macrophages are preactivated (prob-
ably by LPS derived from normal intestinal bacteria leaking
Figure 1. Listeria titers in organs of different mouse strains deficient for
molecules in the IFN signaling pathway. (A) Mice deficient for IFN-
related transcription factors (ICSBP, IRF1, IRF2; filled diamonds) or (B)
mice lacking functional IFN type I (A129; filled diamonds) or type II
(G129; filled circles) receptors and control littermates (open diamonds) were
infected with 5 3 103 CFU of Listeria intravenously. After 5 d bacterial ti-
ters were determined in liver and spleen. Groups of three to four mice
were analyzed. Each symbol represents one mouse. One representative
experiment of two is shown for each strain.
Figure 2. Capacity of ICSBP2/2 spleen cells to transfer Listeria resis-
tance to RAG22/2 mice. Non adherent spleen cells of ICSBP1/1 (open di-
amonds) or ICSBP2/2 (filled diamonds) mice were transferred to RAG22/2
mice. After 24 h the recipients as well as untreated RAG22/2 mice (open
circles) were infected with 2 3 105 CFU of Listeria, and bacterial titers were
determined on day 9 after infection to assess overall protection. Groups of
four to five recipient mice were used. Each symbol represents one mouse.
One of three comparable experiments is shown.925 Fehr et al.
into circulation), this may be an additional factor explaining
the results in A129 mice and also the difference between
IRF12/2 mice held under conventional versus SPF conditions.
Capacity of Adoptively Transferred ICSBP2/2 Spleen Cells to
Correct Immunodeficiency of RAG22/2 Mice. Our results of
anti-Listeria immune response in ICSBP2/2 mice suggested
a major defect of IFN-g-induced macrophage function,
because lymphocytes, especially cytotoxic T cells, but also
B cells, had been shown to function almost normally after
viral infections (36, 39). Therefore macrophage functions
were tested in vivo by adoptive transfer experiments and in
vitro by PEM cultures.
RAG22/2 mice are devoid of functional T and B cells,
but have normal macrophages and natural killer cells (47).
When infected with an intermediate dose of Listeria, they are
able to control bacterial replication comparable to nude mice
(46), but cannot eliminate the pathogen. To test whether
ICSBP-deficient T cells could develop normal specific anti-
Listeria immunity, we transferred on day 0 macrophage-
depleted ICSBP2/2 spleen cells into RAG22/2 mice, chal-
lenged them with a high dose of Listeria (2 3 105 CFU i.v.)
on day 1 and evaluated Listeria titers in liver and spleen on
day 10 to look for efficiency of the specific immune re-
sponse. As a positive control normal spleen cells and as a
negative control no spleen cells were transferred. The result
(Fig. 2) revealed no difference of Listeria counts between
recipients of ICSBP2/2 and ICSBP1/1 spleen cells; in con-
trast RAG22/2 mice that did not receive spleen cells ex-
hibited 100- (spleen) to 1,000-fold (liver) higher bacterial
counts. This result indicates that ICSBP2/2 splenocytes (es-
pecially the mutant T cells) were able to promote elimina-
tion of Listeria as successfully as normal lymphocytes in co-
operation with the intact macrophage compartment of the
RAG22/2 mouse.
Analysis of Listeria Killing in an In Vitro PEM Culture.
To evaluate listericidal activity of macrophages of the dif-
ferent mutant mouse strains, we tested PEM in an in vitro
killing assay. ICSBP2/2, IRF12/2, and IRF22/2 PEM were
elicited by starch injection intraperitoneally, plated onto cover
slips and cultured as described in Materials and Methods.
After 42 h the cultures were infected with Listeria in vitro,
and the number of infected cells determined at time point
t0 and after 7 h of infection. The results (Fig. 3) show that
Figure 3. Elimination of Listeria from a PEM culture stimulated with
LPS, IFN-g or both. PEM of mice deficient for different IFN-related
transcription factors were elicited with starch solution, harvested after 5 d
and put into culture on cover slips under presence of the indicated stimu-
lators. After 42 h (at time point t0) they were infected with Listeria and al-
lowed to digest the bacteria during 7 h. Then, cover slips were taken out,
dried and May-Grünwald-Giemsa stained. The number of infected mac-
rophages was counted under the microscope, compared to the infection
rate at t0 and expressed as difference in percentage of infected cells. Error
bars represent standard deviation. Examples for absolute numbers: the
number of infected macrophages at t0 was between 80 and 106/200 for all
strains; the number of infected cells in IFN-g-stimulated cultures after 7 h
of digestion was 19/200 for wild-type and 168/200 for ICSBP2/2 mice.
Figure 4. NO production and respiratory burst in PEM cultures. PEMs
of mice deficient for different IFN-related transcription factors were cul-
tured as described in Fig. 3. (A) After 42 h NO production was measured
by determination of nitrite accumulation in the culture supernatants by
using Griess reagent. Values are calculated as nmol nitrite per 105 cells.
One of three independent and comparable experiments is shown. (B)
Respiratory burst capacity of the same PEMs was determined by measur-
ing H2O2 production by chemiluminescence after stimulation with PMA.
Values were first calculated as nmol H2O2 per 105 cells, and then a stimu-
lation index of stimulated versus unstimulated cultures was determined
(stimulation index of unstimulated culture 5 1). Error bars indicate stan-
dard deviation.926 Role of Interferon Consensus Sequence Binding Protein in Murine Listeriosis
Figure 5. Listeria replication and iNOS expression in the liver after infection with Listeria. ICSBP2/2 (D–H), IRF12/2 (L, M), IRF22/2 (N, O), and
control mice (A–C, I, K) were infected with 5 3 103 CFU of Listeria. After 5 or 6 d liver and spleen were taken out. Conventional HE staining (A, D)
and immunohistology for Listeria (B, E, G, I, L, N) and iNOS (C, F, H, K, M, O) was performed using polyclonal primary antibodies. Magnifications:
(A, D), 335, (B, C, E, F, I–O), 360 (G, H), 3220.927 Fehr et al.
PEM of ICSBP2/2 and, to a lesser degree, IRF22/2 mice
allowed enhanced replication of Listeria, whereas PEM of
IRF12/2 and normal mice were able to reduce the bacte-
rial load in these macrophage cultures. Also the number of
bacteria per macrophage was higher in ICSBP2/2 mice
(mostly more than 10 bacteria/cell) compared to their con-
trols (0–4 bacteria/cell), revealing some macrophages with
plenty of Listeria and typical comet tails (18). This finding
confirms the defect in macrophage effector function, which
correlates with the in vivo susceptibility of these mouse
strains to Listeria (ICSBP2/2 .IRF22/2 .IRF12/2).
Evaluation of NO Synthesis and Respiratory Burst as Anti-
Listeria Effector Functions of Macrophages. The effector mechan-
sim responsible for listericidal properties of macrophages is
widely studied and still not clearly defined. ROI (14–19) as
well as RNI (20–23) have been proposed to be of major
importance. Therefore NO production (measured as nitrite
accumulation in culture medium) and respiratory burst
upon PMA stimulation (H2O2 production measured by
chemiluminescence) were tested in PEM cultures stimu-
lated with LPS and/or IFN-g as described in Materials and
Methods. NO production (Fig. 4 A) was absent in IRF12/2
mice confirming earlier results that iNOS cannot be in-
duced by IFN type I or II combined with LPS and/or
TNF in the absence of IRF1 (48, 49). In contrast, iNOS
activity was normal in ICSBP2/2 and in IRF22/2 mice as
well as in G129 mice (50). This finding in IRF22/2 mice
differs from recently published results (51). The high sus-
ceptibility of the ICSBP2/2 and G129 strains to Listeria in-
fection in vivo and in vitro indicates that the NO effector
mechanism does not play a limiting role in Listeria clearance.
The phenotype of IRF12/2 mice found here is compatible
to the published results of Listeria infection in iNOS-deficient
mice (23). These mice showed also a slightly enhanced
bacterial replication (10–100-fold) and a higher lethality to
Listeria infection, but only after injection of 6 3 104 CFU
i.v. The LD50 of iNOS-deficient mice was only a factor 10
lower compared to their normal littermates, whereas in the
case of ICSBP2/2 mice this difference is more than 10,000-
fold (Table 1; LD50 for C57BL/6 mice is z3 3 105 CFU
[52]). The fact that iNOS induction in the susceptible
strains (ICSBP2/2, IRF22/2) was higher than in controls
(Figs. 4 A, and 5) could even indicate that NO may have a
toxic effect on infected cells during murine listeriosis.
With respect to respiratory burst upon PMA challenge,
all mouse strains showed comparable basal activity of un-
stimulated cultures; however, in ICSBP2/2 and IRF22/2
mice ROI production could not be stimulated by IFN-g
(Fig. 4 B) and was 3–5 min delayed compared to control
mice (data not shown). This finding suggests that deficient
ROI production might be partially responsible for the high
susceptibility of ICSBP2/2 mice to Listeria, but it cannot
fully explain the drastic phenotype of these mice. At least a
third effector pathway not yet known may have to be
evoked to explain this phenotype (see Discussion). In addi-
tion, the fact that LPS-induced respiratory burst was en-
hanced in IRF22/2 mice correlates inversely with a recently
published finding of high IRF2 levels in LPS-hyporespon-
sive mouse strains (53). Thus, IRF2 may mediate the mac-
rophage deactivating effect of LPS (42).
Expression of iNOS in Liver and Spleen after Listeria Infection
of ICSBP2/2 and IRF22/2 Mice, but not of IRF12/2 Mice.
Apart from macrophages hepatocytes are a major target cell
in murine listeriosis. They are infected by direct cell-to-cell
spread of the pathogen that is able to associate with actin
filaments of the cytoskeleton (54). Hepatocytes can pro-
duce NO. Therefore, to see whether the phenotype of
ICSBP2/2 and IRF22/2 mice is due to a localized inability
of iNOS expression in the liver, immunohistological analy-
sis of iNOS expression in liver (Fig. 5) and spleen (not shown)
after Listeria infection was performed. Mice of the three
gene-targeted and control strains were infected with Listeria
(5 3 103 CFU i.v.). On day 5 or 6 liver and spleen were
taken, cryosectioned, and then immunostained for Listeria
and for iNOS with an appropriate polyclonal rabbit antise-
rum. Induction of iNOS comparable to wild-type mice
could be demonstrated in all strains except IRF12/2 (Fig.
5, C, F, K, M, O). It was abundant in regions where Listeria
and abcesses were found (detail shown in Fig. 5, G and H).
In addition fulminant Listeria proliferation in liver (Fig. 5 E)
and spleen of ICSBP2/2 mice was found with accompany-
ing tissue destruction (Fig. 5 D) correlating with the high
bacterial titers (Fig 1). This analysis also shows that the sus-
ceptibility of ICSBP2/2 and IRF22/2 mice to Listeria is not
due to inefficient NO production in the liver. In contrast,
IRF12/2 mice were well protected and did not express
iNOS in the liver. This cannot be explained by earlier de-
cline of the bacterial load because these mice had equal
Listeria titers in the liver as wild-type mice 5 d after infec-
tion (Fig. 1 A). The same analysis was performed on spleen
sections with comparable results (not shown).
Discussion
The type II IFN system has been shown to be of crucial
importance for immunity against Listeria, because mice de-
ficient for IFN-g (11) or the type II IFN receptor (12) are
highly susceptible to this bacterium. However, the intracel-
lular signalling pathway and the final effector mechanisms
involved in Listeria clearance are only incompletely under-
stood. The presented analysis of three gene-targeted mouse
strains deficient of ICSBP, IRF1, or IRF2 with respect to
their capacity to survive and eliminate Listeria in vivo and
in vitro and to the ability of their macrophages to respond
with ROI or RNI production upon IFN-g stimulation
suggests three major conclusions: (a) ICSBP/IRF2 com-
plex (but not IRF1) is of crucial importance for murine in-
nate immunity to Listeria in vivo and in vitro, (b) iNOS
induction and NO synthesis play no limiting role for anti-
Listeria activity of macrophages upon IFN-g stimulation, (c)
stimulation of ROI production by IFN-g together with a
postulated third yet unknown effector pathway in mac-
rophages may be responsible for protection in the early
phase of primary Listeria infection. The role of NO for an-
timicrobial activity of macrophages has been tested in other928 Role of Interferon Consensus Sequence Binding Protein in Murine Listeriosis
infectious model systems. It seems to play an important role
in leishmaniasis (55, 56) and tuberculosis (48), but has no
limiting effect in toxoplasmosis (57) and listeriosis (this study,
references 58, 59).
Our results of the analysis of mice deficient for IFN type
I or II receptors revealed surprisingly that the type I IFN
receptor-deficient mice (A129) were better protected than
their normal littermates. This finding may reveal in vivo
competition of transcription factors of both signaling path-
ways at the DNA binding level (45) suggesting that absence
of the type I system enhances function of the type II system
and concurrently Listeria protection. A potentiating effect
of LPS leaking through from intestinal bacteria leading to
macrophage preactivation may be involved.
From the analysis of TNF receptor 1-deficient (13) mice
it is known that TNF-a is a second important cytokine for
protection against Listeria. It is produced by macrophages
upon infection with Listeria and may act via the following
two pathways: (a) the SCID model revealed that TNF-a is
necessary for activation of NK cells that then produce IFN-g
to further induce TNF receptor 1 and TNF-a expression
(60, 61) and macrophage effector functions (4); (b) mac-
rophage- or gd T cell–derived TNF-a may act in an auto-
crine or paracrine fashion directly on macrophages to activate
anti-Listeria effector molecules. Involvement of the ICSBP/
IRF2 complex in the signaling cascade of the TNF recep-
tor could theoretically explain the described in vivo find-
ings, but this has not been formally demonstrated so far. In
addition, another transcription factor, NF-IL6, which can
be upregulated by LPS/CD14 and also by TNF-a (62), is
important for clearance of Listeria as demonstrated in the
NF-IL6–deficient mice (63).
From our findings in three different mouse strains and
from the published literature, the following model of sig-
naling events in activation of anti-Listeria immunity may be
proposed (Fig. 6): after activation of IFN receptors various
tyrosine kinases are induced and STAT proteins phosphor-
ylated (Table 1); they regulate the induction and activation
of transcription factors of the IRF family among which the
exclusively IFN-g-dependent ICSBP mediates protection
against Listeria. Two major questions remain open: (a)
What molecules are involved in the signalling of the TNF
receptor that could explain its importance for anti-Listeria
immunity (ICSBP, NF-IL6, other transcription factors, in-
direct effect via NK cell activation)? (b) How do macro-
phages kill Listeria? Our results, but also the published ones
on IFN type II receptor- and iNOS-deficient mice, rather
argue against RNI production being a limiting factor. ROI
may be involved since ICSBP- and NF-IL6–deficient mice
had reduced respiratory burst, and this correlated with high
susceptibility to Listeria infection. But still there may be a
potential third mechanism involved to explain the drastic
phenotype of ICSBP2/2 mice. Studies on iron metabolism
of peritoneal macrophages (64) and murine b-thalassemia
(65) suggested that iron scavengers lead to enhanced, and
iron overload to reduced, resistance to Listeria by direct in-
terference with the essential bacterial iron metabolism.
Whether IFN-g– and/or TNF-a–mediated enhancement
of iron-binding proteins can explain resistance to murine
listeriosis remains to be investigated.
Figure 6. Proposed possible
signaling events in macrophages af-
ter Listeria infection. IFN-g–induced
ICSBP is of crucial importance
for protection in murine listeriosis,
probably partly via ROI produc-
tion. G-CSF (66) plays a minor
and IRF1-induced RNI (23) no
limiting role for bacterial resis-
tance. A potentiating effect or an
additional factor is postulated.
How ICSBP, NF-IL6 or other
transcription factors are involved
in TNF-mediated protection
against  Listeria remains to be de-
termined.
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